Metrics to compare | FDC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipFDCPeersSector | |
|---|---|---|---|---|
P/E Ratio | 19.6x | 31.3x | −0.2x | |
PEG Ratio | 0.50 | 0.92 | 0.00 | |
Price / Book | 2.3x | 4.2x | 2.6x | |
Price / LTM Sales | 2.7x | 4.2x | 2.7x | |
Upside (Analyst Target) | - | 12.6% | 68.5% | |
Fair Value Upside | Unlock | 5.6% | 11.5% | Unlock |
FDC Limited, together with its subsidiaries, manufactures and trades in pharmaceutical products in India, the United States, and internationally. The company offers pharmaceutical formulations for various therapeutic segments, including anti-infectives, gastroenterology, ophthalmology, anti-diabetics, cardiovascular care, respiratory care, gynaecology, dermatology, paediatrics, analgesics, vitamins, and nutritional health in the form of tablets, capsules, oral liquids, ophthalmic drops, topical preparations, and paediatric-friendly solutions. It also provides functional food, such as flavoured oral rehydration solution powders, ready-to-drink electrolyte beverages, vitamin-enriched supplements, antioxidant blends and protein-fortified drinks; and various active pharmaceutical ingredients. The company sells its products under the Zifi, Zifi-0, Zocon, Mycoderm, Zathrin, Victofol, Cotaryl, Ziglim-M, Amodep-AT, MumMum 1, Victofol Injection, Simyl MCT, Victofol – C, Electral, and Enerzal brands. It also exports its products to approximately 50 countries. FDC Limited was founded in 1936 and is based in Mumbai, India.